Research workbench
Crystal structure of apo PTMU3
Analyse Crystal structure of apo PTMU3 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- PDB
- 6OMP
- Type
- protein
- Length
- 712 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- PTMU3
- UniProt
- A0A0A0UVH9
- Ligands
- MN
- Pockets
- 5 · best druggability 0.80
Structure
x-ray diffraction · 1 distinct chain · 45% helix, 17% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A, B | PTMU3 | protein | 356 | 45% helix, 17% strand | A0A0A0UVH9 |
Ligands and binding sites
- MN · Manganese (II) ion · metal · 7 copies · chains A, B
- ACT · Acetate ion · additive · 10 copies · chains A, B
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 906 | 0.80 | 0.82 | 57 | empty |
| 2 | 618 | 0.79 | 0.84 | 43 | empty |
| 3 | 232 | 0.54 | 0.77 | 50 | ACT |
| 4 | 137 | 0.44 | 0.76 | 23 | empty |
| 5 | 60 | 0.36 | 0.79 | 12 | empty |
Interfaces
1 interface between chains.
- A–B · 2585 Ų buried · 39 hydrogen bonds · protein-protein
Compared structures
- 6OMP · Crystal structure of apo PtmU3 · the same entry in another collection · chain B against B, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt A0A0A0UVH9
- Elsewhere: RCSB PDB 6OMP · PDBe 6OMP · UniProt A0A0A0UVH9
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.